Pig Lung Transplanted Into a Human In Major Scientific First

An anonymous reader quotes a report from ScienceAlert: A genetically modified pig lung transplanted into a brain-dead human patient functioned for nine days in a new achievement that reveals both the promise and significant challenges of xenotransplantation. Over the course of the experiment, the patient showed increasing signs of organ rejection before scientists at the First Affiliated Hospital of Guangzhou Medical University in China terminated the experiment, allowing the recipient to pass away. It's the first time a pig lung has been transplanted into a human patient, demonstrating a significant step forward, and giving scientists new problems to solve as they develop this emerging medical technique further.

The goal of the experiment was not to achieve a successful transplantation on the first try -- that would have been pretty incredible, but not a realistic expectation. Rather, the researchers wanted to observe how the patient's immune system responded to the transplanted organ. The patient was a 39-year-old man who was declared brain-dead by four separate clinical assessments after undergoing a brain hemorrhage. His family provided written informed consent for the experiment. The donor pig is what is known as a six-gene-edited pig, a Bama miniature pig with six CRISPR gene edits, housed in an isolated facility with rigorous disinfection protocols. These edits are all focused on minimizing the immune and inflammatory responses of the patient.

In a careful surgical procedure, the pig's left lung was placed into the patient's chest cavity, and connected to their airways, arteries, and veins. The paper does not explain the fate of the pig, but donor pigs do not typically survive the removal of a major organ. The patient was also treated with a number of immunosuppressants that the researchers adjusted according to changes observed in the patient's body over time. Initially, all seemed well, with none of the immediate signs of hyperacute rejection in the critical few hours following the procedure. However, by 24 hours after the transplant had taken place, severe swelling (edema) was observed, possibly as a result of blood flow being restored to the area of the transplant. Antibody-mediated rejection damaged the tissue further on days three and six of the experiment. The result of the damage was primary graft dysfunction, a type of severe lung injury occurring within 72 hours of a transplant, and the leading cause of death in lung transplant patients. Some recovery was taking place by day nine, but the experiment had run its course. The research has been published in Nature Medicine.

Read more of this story at Slashdot.